Mehr erfahren

Mehr erfahren

Mehr erfahren

Mehr erfahren

Mehr erfahren

Mehr erfahren

Mehr erfahren

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Mehr erfahren

Mehr erfahren

Öffentliche Ausschreibung nach VOB/A §3

Ablauf der Angebotsfrist: 21.04.2026 10:30 Uhr

Mehr erfahren

Öffentliche Ausschreibung nach VOB/A §3

Ablauf der Angebotsfrist: 21.04.2026 10:00 Uhr

Mehr erfahren

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

Mehr erfahren

A population-based cohort study provides new data on the prevalence of early-stage type 1 diabetes in young adults, addressing a gap in epidemiological research. Using samples from the LISA and GINIplus cohorts and methodologies established in the…

Mehr erfahren

A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can distinguish lipid species in living cells – in particular cholesterol and sphingomyelin – and map them without the need for…

Mehr erfahren

How can scientific breakthroughs reach the people more quickly? This question was the focus of the Helmholtz Munich Expert Hour on March 25 in the German Bundestag. Under the title “From Research to Patients – Translation and AI in Medicine”,…

Mehr erfahren

“Metabolic Programs in Cancer Immunotherapy - looking at T cells and Host Factors”

Mehr erfahren

At its most recent plenary session, the Bavarian Academy of Sciences and Humanities (BAdW) elected 13 distinguished scholars as new members. Among them are three researchers from Helmholtz Munich: Prof. Maria-Elena Torres-Padilla, Prof. Fabian Theis,…

Mehr erfahren

As the Director of the newly established Institute for Metabolism and Immunology, Prof. Carolin Daniel strives to cultivate an environment that promotes curiosity-driven research while ensuring a clear focus on translational impact and long-term…

Mehr erfahren

EDENT1FI (“European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception”), a research project led by Prof. Anette-Gabriele Ziegler from Helmholtz Munich and Prof. Chantal Mathieu from the KU Leuven, has reached an…

Mehr erfahren

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

Mehr erfahren

Biomedical engineering applies engineering principles to address challenges in medicine and biology. To explore ways of strengthening biomedical engineering as a driver of innovation and growth in Europe, EMBO and the Helmholtz Bioengineering…

Mehr erfahren

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Mehr erfahren

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Mehr erfahren

In a joint guest article published in Table.Media, bioengineering expert Vasilis Ntziachristos and deep-tech specialist Francis de Véricourt examine the key levers needed to sustainably advance biomedical innovation in Germany and Europe. The two…

Mehr erfahren

On March 5, Google opened its first German AI Center in Berlin. The event was attended by representatives from politics, business, and science, including Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, Berlin's…

Mehr erfahren

Helmholtz Munich and Novartis Biomedical Research are launching a four-year collaboration to advance kidney disease research. Starting in early 2026, the partnership will work to develop an integrated, cross-species “kidney disease atlas” at…

Mehr erfahren

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading clinics across Germany to translate research findings directly and purposefully into new therapeutic approaches — and,…

Mehr erfahren

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland
 

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Mehr erfahren

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

Mehr erfahren

Dr. Arcangela Iuso from the Institute of Neurogenomics at Helmholtz Munich was awarded the Eva Luise Köhler Research Award. The foundation thus honors a highly innovative research project on RNA base editing for a rare neurodegenerative disease.

Mehr erfahren